PhD Immunoglobulin A nephropathy (known as IgA nephropathy or Berger's disease) is a rare kidney disease that occurs when the body's immune system response causes IgA antibodies to build up in the ...

National Health Service: “IgA Nephropathy.” Mayo Clinic: “IgA nephropathy (Berger's disease).” Clinical Journal of the American Society of Nephrology: “Recurrence of IgA Nephropathy ...

IgA nephropathy (also known as IgAN or Berger’s disease) is an autoimmune disorder that occurs when the immune system ...

The biopsy showed that Miller had IgA nephropathy, which was difficult news to receive. “It changed my life quite a bit, as you can imagine, getting a diagnosis for a rare disease that there’s ...

IgA nephropathy (IgAN) is characterized by the deposition of IgA1-containing immune complexes in the glomerular mesangium. The pathogenesis follows a 4-hit cascade: ...

The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary immunoglobulin A (IgA ... also known as Berger's disease, progress to kidney ...

Magistroni et al. retrospectively reviewed 237 IgA nephropathy cases diagnosed from 1981 to 2004 to identify indicators of disease progression that might help to guide treatment. Multivariate ...

Richard Lafayette, MD, FACP, Stanford University Medical Center, explains the significance of this second approval in a month ...

Shortly after claiming FDA approval for its Filspari therapy for rare kidney disease IgA Nephropathy (IgAN ... also known as Berger’s disease. It occurs when antibodies accumulate in the ...

Adults recently diagnosed with immunoglobulin A nephropathy who were assigned sparsentan as first-line therapy experienced rapid and sustained reductions in proteinuria, according to ...

Our extensive research on the Global IgA Nephropathy Disease Treatment Market (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, investment ...